| Literature DB >> 23587298 |
Guang-Hua Jin1, Li-Xin Chen, Xiao-Wu Deng, Xiao-Wei Liu, Ying Huang, Xiao-Bo Huang.
Abstract
BACKGROUND AND PURPOSES: To compare the dosimetry for the left-sided breast cancer treatment using five different radiotherapy techniques.Entities:
Mesh:
Year: 2013 PMID: 23587298 PMCID: PMC3648459 DOI: 10.1186/1748-717X-8-89
Source DB: PubMed Journal: Radiat Oncol ISSN: 1748-717X Impact factor: 3.481
Figure 1An example of the contour of PTV and PRV-OARs.
The optimization objective used for inverse IMRT planning
| PTV | V52Gy ≤1%, V51Gy ≤ 4%; D50% = 50Gy; V49Gy ≥ 100%,V50Gy ≥ 95% |
| PRV-contralateral breast | Dmax ≤ 3Gy |
| PRV-left lung | V10Gy ≤ 30%; V20Gy ≤ 20%; V30Gy ≤ 10% |
| PRV-coronary artery region | V10Gy ≤ 25%, V20Gy ≤ 15%, V30Gy ≤ 5% |
| PRV-heart | V10Gy ≤ 20%; V20Gy ≤ 15%; V30Gy ≤ 20% |
The PTV dose parameters of five plans
| D98(Gy) | 47.3±0.4 | 47.0±0.4 | 47.0±0.6 | 47.3±0.6 | 46.4±0.6 |
| D2(Gy) | 53.2±0.6 | 52.0±0.6 | 52.7±0.6 | 52.4±0.5 | 53.4±0.7 |
| D50(Gy) | 50.6±0.6 | 50.7±0.4 | 50.7±0.4 | 50.4±0.4 | 51.0±0.4 |
| V95% | 96.2±1.6A | 95.6±1.6A | 96.8±1.7A | 96.1±1.7A | 94.7±1.2A |
| CI | 2.0±0.5Aa | 1.7±0.4A | 1.6±0.3Ab | 1.3±0.1Bb | 1.4 ±0.2Bb |
| HI | 0.13±0.02A | 0.11±0.02B | 0.11±0.03B | 0.11±0.02B | 0.14±0.02A |
A had significant difference with B (p<0.05), and, a had significant difference with b (p<0.05). Otherwise the difference was not significant between any two (p>0.05).
Figure 2The dose distribution of five plans in isocenter slice.
Dose comparison of the PRV-left lung between the five plans
| Dmean(Gy) | 8.6±2.6A | 8.2±2.4A | 6.8±2.0Ba | 9.3±3.8A | 10.1±2.5Bb |
| V5 (%) | 25.9±6.6A | 24.6±6.1A | 23.4±5.6A | 49.4±9.5B | 50.3±13.3B |
| V10 (%) | 20.9±5.9A | 19.1±5.5A | 17.7±4.9A | 26.8±6.2B | 29.9±8.0B |
| V20 (%) | 16.9±5.4Ab | 15.0±5.0A | 12.9±4.2Aa | 14.6±4.5A | 16.4±4.8Ab |
| V30 (%) | 14.2±5.1B | 12.2±4.6A | 9.6±3.9A | 9.6±3.9A | 10.3±3.4A |
| V40 (%) | 10.9±4.6A | 8.7±3.9A | 6.3±3.2B | 4.7±2.5B | 5.1±2.4B |
A had significant difference with B (p<0.05), and, a had significant difference with b (p<0.05). Otherwise the difference was not significant between any two (p>0.05).
Comparison of the PRV-heart dose parameters in five plans
| Dmean(Gy) | 3.7±2.0Ab | 3.2±1.9A | 2.2±1.0Aa | 4.4±1.9Ab | 4.6±1.7Ab |
| V5 (%) | 10.2±6.0A | 8.9±5.9A | 6.3±3.6A | 26.2±21.1B | 26.1±15.1B |
| V10 (%) | 7.5±5.0Aa | 6.1±4.8A | 3.5±2.4Ab | 6.8±5.4Aa | 6.9±4.9Aa |
| V20 (%) | 5.6±4.2A | 4.3±4.0A | 2.0±1.7Bb | 2.1±2.1Bb | 2.5±2.4Ba |
| V30 (%) | 4.2±3.5A | 3.2±3.3A | 1.2±1.3B | 1.0±1.3B | 1.1±1.5B |
| V40 (%) | 3.0±2.7A | 2.0±2.2A | 0.6±0.9B | 0.3±0.7B | 0.4±1.0B |
A had significant difference with B (p<0.05), and, a had significant difference with b (p<0.05). Otherwise the difference was not significant between any two (p>0.05).
Planned dose of PRV-coronary artery in five plans
| Dmean(Gy) | 19.4±10.9A | 15.5±10.2A | 8.9±5.2B | 9.9±4.7B | 11.0±4.6B |
| V5 (%) | 63.9±26.9A | 56.8±26.8Aa | 46.2±21.9B | 66.2±28.2A | 82.0±23.3Ab |
| V10 (%) | 52.0±28.3A | 42.4±24.6Ba | 25.6±17.8Bb | 28.6±18.3Bb | 35.2±20.7B |
| V20 (%) | 40.9±27.1A | 31.2±26.6A | 12.4±14.6B | 11.9±14.5B | 12.9±14.3B |
| V30 (%) | 32.2±25.5A | 23.5±25.0A | 6.4±10.6B | 5.5±9.9B | 4.5±8.7B |
| V40 (%) | 22.3±33.0A | 14.3±19.9A | 2.6±5.9B | 1.3±4.0B | 1.5±6.2B |
A had significant difference with B (p<0.05), and, a had significant difference with b (p<0.05). Otherwise the difference was not significant between any two (p>0.05).
The dose parameters of PRV-coronary artery of five plans
| Dmean(Gy) | 0.4±0.4A | 0.4±0.4A | 0.4±0.3A | 1.6±0.7B | 1.9±1.0B |
| V2 (%) | 1.7±3.6A | 2.2±3.9A | 1.5±2.9A | 29.4±21.2B | 33.1±29.9B |
| V3 (%) | 0.6±1.9A | 0.6±2.0A | 0.2±0.6A | 13.9±15.2B | 15.2±22.1B |
| V4 (%) | 0.4±1.5A | 0.4±1.6A | 0.1±0.3A | 5.8±8.1Ba | 7.5±13.0Bb |
| V5 (%) | 0.3±1.3A | 0.3±1.4A | 0.0±0.2A | 1.6±3.2A | 4.0±7.5B |
| V10 (%) | 0.2±0.9A | 0.2±0.9A | 0.0±0.0A | 0.0±0.0A | 0.0±0.0A |
A had significant difference with B (p<0.05), and, a had significant difference with b (p<0.05). Otherwise the difference was not significant between any two (p>0.05).
Score table of the five treatment techniques
| PTV | HI | 1 | 1 | 1 | 1 | 0 |
| | CI | 0 | 0 | | 1 | 1 |
| | V47.5 | 1 | 0 | 1 | 1 | 0 |
| PRV-l- lung | Dmean | 0 | | 1 | 0 | 0 |
| | V5 | 1 | 1 | 1 | 0 | 0 |
| | V10 | 1 | 1 | 1 | 0 | 0 |
| | V20 | 0 | 0 | 1 | 0 | 0 |
| | V30 | 0 | 1 | 1 | 1 | 1 |
| | V40 | 0 | 0 | 1 | 1 | |
| PRV-Heart | Dmean | 0 | 1 | 1 | 0 | 0 |
| | V5 | 1 | 1 | 1 | 0 | 0 |
| | V10 | 0 | | 1 | 0 | 0 |
| | V20 | 0 | 0 | 1 | 1 | 1 |
| | V30 | 0 | 0 | 1 | 1 | 1 |
| | V40 | 0 | 0 | 1 | 1 | 1 |
| PRV-coronary artery | Dmean | 0 | 0 | 1 | 1 | 1 |
| | V5 | 0 | | 1 | 0 | 0 |
| | V10 | 0 | | 1 | 1 | 1 |
| | V20 | 0 | 0 | 1 | 1 | 1 |
| | V30 | 0 | 0 | 1 | 1 | 1 |
| | V40 | 0 | 0 | 1 | 1 | 1 |
| PRV-r-breast | Dmean | 1 | 1 | 1 | 0 | 0 |
| | V2 | 1 | 1 | 1 | 0 | 0 |
| | V3 | 1 | 1 | 1 | 0 | 0 |
| | V4 | 1 | 1 | 1 | 0 | 0 |
| | V5 | 1 | 1 | 1 | 0 | 0 |
| | V10 | 1 | 1 | 1 | 1 | 1 |
| Score | 10 | 12 | 26 | 14 | 12 | |
The blank scoring: one who cannot be judged as superior nor inferior since it was not significant differ from both (p>0.05).
Figure 3The relationship between in dose volume of heart and coronary artery. The abscissa and ordinate respectively represent the dose volume of heart and coronary artery. The red curve is the fitting curve.